The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,000,510 in first-year total cost, median $236,819.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]7
- Special Emphasis Panel[ZAR1 MEP (M2)]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- JOHNS HOPKINS UNIVERSITY1
- MAYO CLINIC ROCHESTER1
- UNIVERSITY OF KENTUCKY1
- UNIVERSITY OF MARYLAND BALTIMORE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Surgery vs. conservative care for meniscal tear after unsuccessful PT: an RCT1R34AR082021-01 | KATZ, JEFFREY NEIL | BRIGHAM AND WOMEN'S HOSPITAL, MA | $249,885 | ZAR1 |
| 2023 | Using Patient Incentive Payments to Reduce Smoking Associated Surgical Complications Following Lower Extremity Trauma: A randomized Clinical Trial1R34AR082087-01 | CASTILLO, RENAN C | JOHNS HOPKINS UNIVERSITY, MD | $241,638 | AMSC |
| 2023 | A Planning Grant for a Multicenter Randomized Clinical Trial Comparing Hip Arthroplasty to Internal Fixation for Minimally Displaced Femoral Neck Fractures1R34AR082550-01 | O'HARA, NATHAN NOELSLOBOGEAN, GERARD | UNIVERSITY OF MARYLAND BALTIMORE, MD | $231,999 | AMSC |
| 2022 | The Local Infiltration Therapy (LIT) Trial for Pain Control Following Hip Fracture Fixation1R34AR079672-01A1 | MATUSZEWSKI, PAUL EDWARD | UNIVERSITY OF KENTUCKY, KY | $369,907 | AMSC |
| 2022 | A Superiority Trial of Radiofrequency Ablation for Low Back Pain (ASTRAL)1R34AR080279-01A1 | FRIEDLY, JANNA LSURI, PRADEEP | UNIVERSITY OF WASHINGTON, WA | $309,984 | AMSC |
| 2022 | Foundations for a Phase 1 Clinical Trial ofCell-based Therapy for Duchenne Muscular Dystrophy1R34AR081536-01 | KANG, PETER B. | UNIVERSITY OF MINNESOTA, MN | $204,600 | AMSC |
| 2021 | Planning Grant for a Clinical Trial Of Cannabidiol For Postoperative Opioid Reduction in Primary Total Knee Arthroplasty1R34AR078435-01A1 | BOEHNKE, KEVIN FOXMANGAGNIER, JOEL JOSEPH | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $205,920 | AMSC |
| 2021 | INvestigative Kyphoplasty Efficacy and Safety Trial (INKTEST)1R34AR079098-01 | JARVIK, JEFFREY GKALLMES, DAVID F | MAYO CLINIC ROCHESTER, MN | $186,577 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.